THYROID DYSFUNCTION, RECOVERY, AND PROGNOSIS IN MELANOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A RETROSPECTIVE REVIEW.

Al Mushref, Mazen

THYROID DYSFUNCTION, RECOVERY, AND PROGNOSIS IN MELANOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A RETROSPECTIVE REVIEW. [electronic resource] - Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists Jan 2020 - 36-42 p. digital

Publication Type: Journal Article

1530-891X

10.4158/EP-2019-0244 doi


Humans
Melanoma
Nivolumab
Prognosis
Retrospective Studies